Top Markets
Coin of the day
Filana Therapeutics, Inc. Filana Therapeutics, Inc.

Filana Therapeutics, Inc.

FLNA
Rank in Stocks #25914
Filana Therapeutics, Inc. is a company dedicated to pioneering new... Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Share Price
$0.9342
Market Cap
$45.13M
Change (1 day)
-3.31%
Change (1 year)
-
Country
US
Trade Filana Therapeutics, Inc. (FLNA)

Category

EPS for Filana Therapeutics, Inc. (FLNA)
EPS as of 2026 TTM: 0
According to Filana Therapeutics, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Filana Therapeutics, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH
$-7.98 -
US